Tsubota Laboratory Incorporated (JP:4890)
:4890
Want to see JP:4890 full AI Analyst Report?
4890 Stock Chart & Stats
¥340.00
¥1.00(0.24%)
At close: 4:00 PM EST
¥340.00
¥1.00(0.24%)
Day’s Range― - ―
52-Week Range¥251.00 - ¥478.00
Previous CloseN/A
Volume43.10K
Average Volume (3M)31.02K
Market Cap
¥6.96B
Enterprise Value¥6.06B
Total Cash (Recent Filing)¥1.47B
Total Debt (Recent Filing)¥85.26M
Price to Earnings (P/E)―
Beta0.08
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.97
Shares Outstanding25,794,300
10 Day Avg. Volume26,720
30 Day Avg. Volume31,016
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)8.77
Price to Sales (P/S)37.86
P/FCF Ratio-12.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetSustained low leverage provides structural resilience versus operational volatility. A conservatively financed balance sheet reduces refinancing risk, preserves borrowing capacity for R&D or working capital, and lengthens runway while management works to restore operating performance.
Equity Capital CushionA substantial equity base lowers insolvency risk during multi-year operational setbacks. It supports continued investment in development and commercialization without immediate reliance on dilutive external funding, enabling management to pursue recovery strategies over several quarters.
Strong Product Gross EconomicsHigh gross margins and prior profitability indicate attractive underlying product economics. If revenue stabilizes, margins can help restore operating profitability since cost of goods is not the primary issue; durable product-level margins support scalable recovery once fixed-cost absorption improves.
Bears Say
Severe Revenue CollapseAn 85% revenue drop is a structural alarm, eroding scale needed to cover fixed costs and fund R&D. Such a collapse can unwind key commercial relationships, delay pipelines, and force expense cuts that impair long-term growth prospects unless revenue recovery is achieved within several quarters.
Persistent Cash BurnMulti-year negative operating cash flow depletes liquidity and forces financing or asset sales. Persistent cash burn constrains strategic options, increases dependency on external capital, and risks dilution or credit stress if losses continue, undermining long-term investment in commercialization and R&D.
Extreme Earnings VolatilitySevere earnings volatility complicates planning and damages credibility with partners and investors. Large swings in EPS and returns signal unstable revenue or one-off hits, making long-range forecasting, hiring, and capital allocation risky and potentially raising the cost of future funding.
Tsubota Laboratory Incorporated News
4890 FAQ
What was Tsubota Laboratory Incorporated’s price range in the past 12 months?
Tsubota Laboratory Incorporated lowest stock price was ¥251.00 and its highest was ¥478.00 in the past 12 months.
What is Tsubota Laboratory Incorporated’s market cap?
Tsubota Laboratory Incorporated’s market cap is ¥6.96B.
When is Tsubota Laboratory Incorporated’s upcoming earnings report date?
Tsubota Laboratory Incorporated’s upcoming earnings report date is Aug 07, 2026 which is in 79 days.
How were Tsubota Laboratory Incorporated’s earnings last quarter?
Tsubota Laboratory Incorporated released its earnings results on May 14, 2026. The company reported -¥9.38 earnings per share for the quarter, missing the consensus estimate of N/A by -¥9.38.
Is Tsubota Laboratory Incorporated overvalued?
According to Wall Street analysts Tsubota Laboratory Incorporated’s price is currently Overvalued.
Does Tsubota Laboratory Incorporated pay dividends?
Tsubota Laboratory Incorporated does not currently pay dividends.
What is Tsubota Laboratory Incorporated’s EPS estimate?
Tsubota Laboratory Incorporated’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tsubota Laboratory Incorporated have?
Tsubota Laboratory Incorporated has 25,794,300 shares outstanding.
What happened to Tsubota Laboratory Incorporated’s price movement after its last earnings report?
Tsubota Laboratory Incorporated reported an EPS of -¥9.38 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.375%.
Which hedge fund is a major shareholder of Tsubota Laboratory Incorporated?
Currently, no hedge funds are holding shares in JP:4890
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tsubota Laboratory Incorporated
Tsubota Laboratory Incorporated engages in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia. The company was incorporated in 2012 and is based in Tokyo, Japan.
Technical Analysis
Sundrug Co
―
Sugi Holdings Co
―
TSURUHA Holdings
―
COSMOS Pharmaceutical Corporation
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―